<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04282083</url>
  </required_header>
  <id_info>
    <org_study_id>001</org_study_id>
    <nct_id>NCT04282083</nct_id>
  </id_info>
  <brief_title>Protocol ITANET - Registry</brief_title>
  <official_title>ITANET -Registry: Multicentric Collection of Cases on Neuroendocrin Gastro-Entero-Pancreatic Tumors (Title in Local Language: ITANET -Registry: Raccolta Multicentrica Dei Casi di Tumore Neuroendocrino Gastro-Entero-Pancreatico)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Italian Association Neuroendocrine Tumors</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Italian Association Neuroendocrine Tumors</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective-prospective observational study with the aim to create an Italian&#xD;
      database for the collection of data on diagnostic approach, therapy and follow up of patients&#xD;
      affected by GEP-NET (gastro-enteric-pancreatic neuroendocrine tumours). Data for&#xD;
      approximately 200 italian patients were already previously collected in the ENETS database&#xD;
      (international database). ENETS decided to interrupt the collection of the data for an&#xD;
      indefinite period. For this reason, through an amendment (number 1) to the protocol, ITANET&#xD;
      (Italian Association Neuro-endocrine Tumors) decided to transfer the italian data into a&#xD;
      national database and to go on with the collection/update of the data, in order not to lose&#xD;
      important clinical information.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each participating site will have access through the reserved area of webpage&#xD;
      https://itanetdb.fullcro.org/, for the data recording in a database which ITANET set-up for&#xD;
      the participating sites in Italy.&#xD;
&#xD;
      The eligible patients, visited at each participating site, will be asked to adhere to the&#xD;
      ITANET-project through a proper Informed Consent obtainment procedure.&#xD;
&#xD;
      Adequate procedures are described in the protocol amendment 1 (and in a proper Standard&#xD;
      Operating Procedure) also for the management of the already collected data in the previous&#xD;
      ENETS registry whose transferral/update/deletion in the ITANET database are well defined and&#xD;
      regulated in order to respect and preserve the patients' rights.&#xD;
&#xD;
      The data will be collected in an pseudo-anonymised way. Each patient will be identified by a&#xD;
      code.&#xD;
&#xD;
      The data management and quality check of the Italian data is deputed to ITANET. The data will&#xD;
      be collected in a retrospective-prospective way, both for the new diagnoses (first visits)&#xD;
      and for the follow up visits of patients with already acquired diagnosis. The enrolment will&#xD;
      take place during the outpatient visit or at the time of the hospitalisation for the&#xD;
      NET-related surgery.&#xD;
&#xD;
      Of course, considering the observational nature of the study, the follow up visits will be&#xD;
      planned on the basis of each patient's clinical need, which is different patient by patient,&#xD;
      according to the disease staging, the primary tumour location, the eventual surgery.&#xD;
&#xD;
      The data flow will be the following:&#xD;
&#xD;
        -  The participating site records the data in the database, waiting to be validated;&#xD;
&#xD;
        -  ITANET has the role to check the recorded data for completeness and coherence in order&#xD;
           to decide whether:&#xD;
&#xD;
             1. The data are acceptable: in this case the data will be validated;&#xD;
&#xD;
             2. There are discrepancies: in this case a query will be sent to the related site in&#xD;
                order to check, correct/explain where applicable and to resubmit the data. The&#xD;
                process starts again until final validation.&#xD;
&#xD;
      The data will be collected yearly to provide several information, such as:&#xD;
&#xD;
        -  Type of NETs followed by the reference national sites for the management of the study&#xD;
           pathology;&#xD;
&#xD;
        -  Tools used for the diagnosis definition and the disease staging;&#xD;
&#xD;
        -  Therapeutic approach (surgical or medical);&#xD;
&#xD;
        -  Disease trend during follow up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 25, 2019</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Incidence of GEP-NET in Italy</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Different localisations of primary GEP-NET</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time between symptoms appearance and diagnosis of GEP-NET</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Type of used and available treatments (medical and surgical)</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">3600</enrollment>
  <condition>Gastro-entero Pancreatic Neuroendocrine Tumors</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients affected by gastro-entero pancreatic neuroendocrine or unknown primary tumor&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age&gt; or = 18 years;&#xD;
&#xD;
          -  histologically/cytologically proved diagnosis of NET OR diagnosis supported by a PET&#xD;
             Gallium 68 positivity and by at least a contrastografic imaging of second level (CT&#xD;
             scan or NMR);&#xD;
&#xD;
          -  Diagnosis of GEP-NET not antecedent 1 year since the Informed Consent signature;&#xD;
&#xD;
          -  Grading G1, G2, G3 according to the classification WHO 2019;&#xD;
&#xD;
          -  Tumor origin in digestive apparatus (GEP NETs) or tumor of unknown origin;&#xD;
&#xD;
          -  Signed Informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known tumor origin different from digestive apparatus (GEP NETs);&#xD;
&#xD;
          -  no evidence of histologically/cytologically proved diagnosis of NET OR diagnosis&#xD;
             supported by a PET Gallium 68 positivity and by at least a contrastografic imaging of&#xD;
             second level (CT scan or NMR);&#xD;
&#xD;
          -  Diagnosis of GEP-NET antecedent 1 year since the Informed Consent signature.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MASSIMO FALCONI</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Raffaele Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Panzuto</last_name>
    <phone>+390633775605</phone>
    <email>fpanzuto@ospedalesantandrea.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Rinzivillo</last_name>
    <phone>+390633775605</phone>
    <email>mrinzivillo@ospedalesantandrea.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas</name>
      <address>
        <city>Rozzano</city>
        <state>Milan</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexia Bertuzzi</last_name>
      <phone>0039 02 8224 4599</phone>
      <email>alexia.bertuzzi@cancercenter.humanitas.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Consorziale Policlinico</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauro Cives</last_name>
      <phone>+390805592859</phone>
      <email>mauro.cives@uniba.it</email>
    </contact>
    <contact_backup>
      <last_name>Anna Ragno</last_name>
      <phone>+390805592759</phone>
      <email>ragnoanna@tiscali.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Policlinico S. Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davide Campana</last_name>
      <phone>+390512143067</phone>
      <email>davide.campana@unibo.it</email>
    </contact>
    <contact_backup>
      <last_name>Giuseppe Lamberti</last_name>
      <phone>+390512143067</phone>
      <email>giuseppe.lamberti8@unibo.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>IRCCS Azienda Ospedaliera-Universitaria di Bologna</name>
      <address>
        <city>Bologna</city>
        <zip>40133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Mastrangelo</last_name>
      <phone>+393477251184</phone>
      <email>laura.mastrangelo@ausl.bologna.it</email>
    </contact>
    <contact_backup>
      <last_name>Elio Jovine</last_name>
      <phone>+393386468200</phone>
      <email>elio.jovine@ausl.bologna.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale Regionale di Bolzano</name>
      <address>
        <city>Bolzano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Ciola</last_name>
      <phone>+39 0471 908468</phone>
      <email>michele.ciola@sabes.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria Goretti</name>
      <address>
        <city>Latina</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiara Spoto</last_name>
      <email>c.spoto@ausl.latina.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MASSIMO FALCONI</last_name>
      <phone>3397473192</phone>
      <email>falconi.massimo@hsr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto Nazionale Tumori</name>
      <address>
        <city>Milan</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Filppo De Braud</last_name>
      <phone>+390223903066</phone>
      <email>Filippo.DeBraud@istitutotumori.mi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale Tumori IRCCS Fondazione G. Pascale</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salvatore Tafuto</last_name>
      <phone>+39 0815903680</phone>
      <email>s.tafuto@istitutotumori.na.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOUSL-IRCCS-Reggio Emilia</name>
      <address>
        <city>Reggio Emilia</city>
        <zip>42100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelina Filice</last_name>
      <email>Angelina.Filice@ausl.re.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituti Fisioterapici Ospitalieri</name>
      <address>
        <city>Roma</city>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marialuisa Appetecchia</last_name>
      <phone>+390652666026</phone>
      <email>marialuisa.appetecchia@ifo.gov.it</email>
    </contact>
    <contact_backup>
      <last_name>Giulia Puliani</last_name>
      <phone>+393400575162</phone>
      <email>giulia.puliani@ifo.gov.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Sant'Andrea Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Panzuto</last_name>
      <phone>+390633775605</phone>
      <email>fpanzuto@ospedalesantandrea.it</email>
    </contact>
    <contact_backup>
      <last_name>Maria Rinzivillo</last_name>
      <phone>+390633775605</phone>
      <email>mrinzivillo@ospedalesantandrea.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Center for Immuno-Oncology Medical Oncology and Immunotherapy University of Siena</name>
      <address>
        <city>Siena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Maio</last_name>
      <phone>+39 0577 586335</phone>
      <email>mmaiocro@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Chiara</name>
      <address>
        <city>Trento</city>
        <zip>38122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elettra Merola</last_name>
      <phone>+39 0461 903954</phone>
      <email>elettra.merola@apss.tn.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 3, 2020</study_first_submitted>
  <study_first_submitted_qc>February 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2020</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GEP-NETs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuroendocrine Tumors</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

